Summary
Acute myeloid leukemia (AML) patients frequently harbor mutations in the epigenetic modifier TET2, which is a DNA demethylase. DNA methylation is an epigenetic modification that occurs predominantly at CpG dinucleotides and have a major impact on transcription. Accordingly, it...
More information & hyperlinks
Web resources: | https://www.bric.ku.dk/research/helin_group/ |